Search
-
The Path to Techquity
Ipsos partnered with the HLTH Foundation to shine a light on existing health tech-related inequities in the U.S. and identify opportunities for the industry to address techquity gaps.
-
ViVE 2022: The Path to Techquity
We’re proud to be participating in ViVE – a conference that merges the leadership of CHIME and the digital marketplace of HLTH to create a technology event focused on the business of healthcare systems.
-
[WEBINAR] Equity and Inclusion in Healthcare
In order for the healthcare system to meet the new demands presented not just by COVID but by an increasingly aging and diverse population, the system and those who work within it will need a human-first approach.
-
[WEBINAR] America in Flux: Moving Forward in a Changed World
Please join us to hear Liza Walworth from Ipsos’ Ethnography Center of Excellence re-visit video excerpts of these families’ experiences and emotional journeys, and Ipsos Behavioral Scientist, Jesse Itzkowitz, who will discuss how they and others can move forward and heal.
-
Americans are excited for the Super Bowl (and the ads) again
With ratings high, brands can expect to get good value for their airtime spend on TV’s biggest day
-
Insight Out: An Ipsos Podcast
A monthly podcast exploring emerging trends, budding innovations and creative ways to get closer to real people in real life.
-
Up Close and Personal: Humanizing Omnichannel
Ipsos has identified six drivers of customer experience, only three of which relate to convenience. The other three are enjoyment, belonging, and status.
-
America in Flux: Looking Ahead
Revisit our recorded webinar to watch ethnographic video segments of our respondents dealing with the challenges of 2021.
-
Empathy Awakened: The power of an empathetic organization
Discover why empathy is essential for your business - not the purely emotional kind but the one that includes purposeful action and delivery.
-
Ipsos clients honored for research in advertising
Advertising Research Foundation highlights campaigns by STEGLUJAN/Merck, Stella Artois and Gardasil 9/Merck.